(Q28271324)

English

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit